...
机译:An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA;
Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA;
ovarian cancer; in vivo screen; targeted therapy; BRD4; MYCN;